This cross-sectional survey study explored (1) individual preferences for health information and decision-making autonomy among Chinese patients with type 2 diabetes (T2DM); (2) their use of mHealth in diabetes self-management; and (3) the relationship between their mHealth use and preferences for health information and decision-making autonomy. Sample size: 200 Mandarin-speaking Chinese patients with T2DM; age range: 26-90 years (Mean: 59.91; SD: 12.17); Mean time since diabetes diagnosis: 7.4 years. Data were collected in February 2017 via a paper-and-pen questionnaire at a general hospital in China. The questionnaire was in Chinese, and measured preferences for health information and decision-making autonomy and mHealth use. Key findings: Participants wanted to have a wide range of health information and participation in decision-making. Gender, health status, and knowledge about diabetes were associated with differences in information wanted and participation in decision-making, but age was not. Half (50.5%) of the participants used smartphones to access the Internet and look for health information; 71% used smartphones to receive/read health-related posts; and 24% had at least one health-related application installed on their smartphones. Smartphone use frequency for health information and participation in decision-making had a significant interaction effect (p < .01), the strength of which varied across seven subscales (specific health condition, treatment, laboratory tests, self-management, complementary/alternative medicine, psychosocial aspects, and healthcare providers). The overall health information wanted was positively related to use of smartphones to receive health-related posts (p <.01). This study has implications for research and clinical practice, especially given the shift from disease-centered to patient-centered care and increasing use of mobile technology in health care.

Disclosure

L. Nie: None. B. Xie: None. Y. Yang: None. S.A. Brown: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.